These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
864 related articles for article (PubMed ID: 24120997)
1. The rescue of microtubule-dependent traffic recovers mitochondrial function in Parkinson's disease. Esteves AR; Gozes I; Cardoso SM Biochim Biophys Acta; 2014 Jan; 1842(1):7-21. PubMed ID: 24120997 [TBL] [Abstract][Full Text] [Related]
2. Impairment of mitochondria dynamics by human A53T α-synuclein and rescue by NAP (davunetide) in a cell model for Parkinson's disease. Melo TQ; van Zomeren KC; Ferrari MF; Boddeke HW; Copray JC Exp Brain Res; 2017 Mar; 235(3):731-742. PubMed ID: 27866262 [TBL] [Abstract][Full Text] [Related]
3. Mitochondrial metabolism in Parkinson's disease impairs quality control autophagy by hampering microtubule-dependent traffic. Arduíno DM; Esteves AR; Cortes L; Silva DF; Patel B; Grazina M; Swerdlow RH; Oliveira CR; Cardoso SM Hum Mol Genet; 2012 Nov; 21(21):4680-702. PubMed ID: 22843496 [TBL] [Abstract][Full Text] [Related]
4. Acetylation as a major determinant to microtubule-dependent autophagy: Relevance to Alzheimer's and Parkinson disease pathology. Esteves AR; Palma AM; Gomes R; Santos D; Silva DF; Cardoso SM Biochim Biophys Acta Mol Basis Dis; 2019 Aug; 1865(8):2008-2023. PubMed ID: 30572013 [TBL] [Abstract][Full Text] [Related]
5. α-Synuclein-induced mitochondrial dysfunction in isolated preparation and intact cells: implications in the pathogenesis of Parkinson's disease. Bir A; Sen O; Anand S; Khemka VK; Banerjee P; Cappai R; Sahoo A; Chakrabarti S J Neurochem; 2014 Dec; 131(6):868-77. PubMed ID: 25319443 [TBL] [Abstract][Full Text] [Related]
6. Polyhydroxylated fullerene derivative C(60)(OH)(24) prevents mitochondrial dysfunction and oxidative damage in an MPP(+) -induced cellular model of Parkinson's disease. Cai X; Jia H; Liu Z; Hou B; Luo C; Feng Z; Li W; Liu J J Neurosci Res; 2008 Dec; 86(16):3622-34. PubMed ID: 18709653 [TBL] [Abstract][Full Text] [Related]
7. The Overcrowded Crossroads: Mitochondria, Alpha-Synuclein, and the Endo-Lysosomal System Interaction in Parkinson's Disease. Lin KJ; Lin KL; Chen SD; Liou CW; Chuang YC; Lin HY; Lin TK Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31731450 [TBL] [Abstract][Full Text] [Related]
8. Neuronal complex I deficiency occurs throughout the Parkinson's disease brain, but is not associated with neurodegeneration or mitochondrial DNA damage. Flønes IH; Fernandez-Vizarra E; Lykouri M; Brakedal B; Skeie GO; Miletic H; Lilleng PK; Alves G; Tysnes OB; Haugarvoll K; Dölle C; Zeviani M; Tzoulis C Acta Neuropathol; 2018 Mar; 135(3):409-425. PubMed ID: 29270838 [TBL] [Abstract][Full Text] [Related]
9. Neuroprotective effects of mesenchymal stem cells through autophagy modulation in a parkinsonian model. Park HJ; Shin JY; Kim HN; Oh SH; Lee PH Neurobiol Aging; 2014 Aug; 35(8):1920-8. PubMed ID: 24629674 [TBL] [Abstract][Full Text] [Related]
10. Mitochondrial metabolic control of microtubule dynamics impairs the autophagic pathway in Parkinson's disease. Cardoso SM; Esteves AR; Arduíno DM Neurodegener Dis; 2012; 10(1-4):38-40. PubMed ID: 22156537 [TBL] [Abstract][Full Text] [Related]
11. Mitochondrial dynamics in Parkinson's disease: a role for α-synuclein? Pozo Devoto VM; Falzone TL Dis Model Mech; 2017 Sep; 10(9):1075-1087. PubMed ID: 28883016 [TBL] [Abstract][Full Text] [Related]
12. Mesenchymal Stem Cells Stabilize Axonal Transports for Autophagic Clearance of α-Synuclein in Parkinsonian Models. Oh SH; Lee SC; Kim DY; Kim HN; Shin JY; Ye BS; Lee PH Stem Cells; 2017 Aug; 35(8):1934-1947. PubMed ID: 28580639 [TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of Parkin at serine 131 by p38 MAPK promotes mitochondrial dysfunction and neuronal death in mutant A53T α-synuclein model of Parkinson's disease. Chen J; Ren Y; Gui C; Zhao M; Wu X; Mao K; Li W; Zou F Cell Death Dis; 2018 Jun; 9(6):700. PubMed ID: 29899409 [TBL] [Abstract][Full Text] [Related]
14. Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson's disease. Rocha EM; De Miranda B; Sanders LH Neurobiol Dis; 2018 Jan; 109(Pt B):249-257. PubMed ID: 28400134 [TBL] [Abstract][Full Text] [Related]
15. TMEM175 deficiency impairs lysosomal and mitochondrial function and increases α-synuclein aggregation. Jinn S; Drolet RE; Cramer PE; Wong AH; Toolan DM; Gretzula CA; Voleti B; Vassileva G; Disa J; Tadin-Strapps M; Stone DJ Proc Natl Acad Sci U S A; 2017 Feb; 114(9):2389-2394. PubMed ID: 28193887 [TBL] [Abstract][Full Text] [Related]
16. Identification of a highly neurotoxic α-synuclein species inducing mitochondrial damage and mitophagy in Parkinson's disease. Grassi D; Howard S; Zhou M; Diaz-Perez N; Urban NT; Guerrero-Given D; Kamasawa N; Volpicelli-Daley LA; LoGrasso P; Lasmézas CI Proc Natl Acad Sci U S A; 2018 Mar; 115(11):E2634-E2643. PubMed ID: 29487216 [TBL] [Abstract][Full Text] [Related]
17. Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases. Hashimoto M; Rockenstein E; Crews L; Masliah E Neuromolecular Med; 2003; 4(1-2):21-36. PubMed ID: 14528050 [TBL] [Abstract][Full Text] [Related]
18. Triptolide Promotes the Clearance of α-Synuclein by Enhancing Autophagy in Neuronal Cells. Hu G; Gong X; Wang L; Liu M; Liu Y; Fu X; Wang W; Zhang T; Wang X Mol Neurobiol; 2017 Apr; 54(3):2361-2372. PubMed ID: 26957304 [TBL] [Abstract][Full Text] [Related]
19. The Upshot of LRRK2 Inhibition to Parkinson's Disease Paradigm. Esteves AR; G-Fernandes M; Santos D; Januário C; Cardoso SM Mol Neurobiol; 2015 Dec; 52(3):1804-1820. PubMed ID: 25394383 [TBL] [Abstract][Full Text] [Related]
20. Acteoside exerts neuroprotection effects in the model of Parkinson's disease via inducing autophagy: Network pharmacology and experimental study. Aimaiti M; Wumaier A; Aisa Y; Zhang Y; Xirepu X; Aibaidula Y; Lei X; Chen Q; Feng X; Mi N Eur J Pharmacol; 2021 Jul; 903():174136. PubMed ID: 33940032 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]